Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.9M Buy
7,993
+204
+3% +$325K 0.97% 30
2026
Q1
$10.3M Buy
7,789
+18
+0.2% +$24.7K 0.68% 43
2025
Q4
$8.31M Sell
7,771
-152
-2% -$159K 0.53% 52
2025
Q3
$7.67M Buy
7,923
+67
+0.9% +$52.7K 0.49% 60
2025
Q2
$6.29M Buy
7,856
+417
+6% +$299K 0.42% 63
2025
Q1
$4.93M Buy
7,439
+467
+7% +$340K 0.35% 67
2024
Q4
$4.83M Buy
6,972
+3,572
+105% +$2.57M 0.33% 67
2024
Q3
$2.83M Buy
3,400
+240
+8% +$215K 0.19% 95
2024
Q2
$3.23M Buy
+3,160
New +$3.04M 0.23% 87

Other funds holding ASML

Boston Family Office's ASML Position: Q2 2026 in Review

Boston Family Office increased its ASML (ASML) stake by 2.6% in Q2 2026, buying an estimated $325K and bringing the position to 7,993 shares worth $15.9M. The position accounts for 0.97% of the portfolio, ranked #30.

Boston Family Office first reported a position in ASML in Q2 2024 and has held it in 9 quarters since. 2,508 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Boston Family Office held 7,993 shares of ASML worth $15.9M as of Q2 2026.
  • Boston Family Office bought 204 ASML shares in Q2 2026, an estimated $325K.
  • ASML made up 0.97% of Boston Family Office's portfolio in Q2 2026, its #30 holding.
  • Boston Family Office first reported a position in ASML in Q2 2024 and has held it in 9 quarters since.
  • 2,508 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Boston Family Office's 13F filing for Q2 2026, filed 12 Aug 2026.